SLS has been in the news 750% more than usual
Dec 30, 2025, 5:32 PM
11.36%
What does SLS do
SELLAS Life Sciences Group, a clinical stage biopharmaceutical company based in New York, develops immunotherapeutics for cancer, including galinpepimut-S and SLS009. The company went public in 2008 and employs 16 staff.
SLS has been in the news recently: SELLAS Life Sciences Group Inc (NASDAQ:SLS) saw its shares rise following positive reactions to new trial-related updates, despite initial premarket declines. This occurred amid a broader market trend where U.S. stock futures fell, with the Dow Jones index dropping over 0.1%.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.